Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content. If you have any issues relating to the topics here, please call the MS-UK Helpline on 0800 7830 518.


 

The findings of a systematic review suggests adolescent obesity could be a risk factor for multiple sclerosis. If future research supports this idea, it “would be of major significance,” according...

John Quarles, an associate professor of computer science at The University of Texas at San Antonio (UTSA), has developed a new virtual reality method of aquatic physical therapy.

Quarles’s...

Patients with multiple sclerosis say they may be wary if their physician gets paid to recruit for clinical trials, a survey has found.

Some 61 per cent of MS patients who'd never...

Urinary tract symptoms affect a large proportion of patients with multiple sclerosis (MS), yet their extent and type is not well-known. A study reported that among a cohort of people with the...

A common antihistamine used to treat symptoms of allergies and the common cold, called clemastine fumarate, partially reversed damage to the visual system in people with multiple sclerosis (MS) in...

A group of T2 weighted hyperintensities that disseminate in what is called a “punctate pattern” (PP) may directly precede the appearance of progressive multifocal leukoencephalopathy (PML) lesions...

A case report of a woman with relapsing-remitting multiple sclerosis (RRMS) who developed shingles while being treated with Tecfidera has raised questions of whether the drug reactivates the...

Secondary health issues are very common in multiple sclerosis (MS) and exerts a significant impact on health-related quality of life (HRQoL), results of two studies published in Neurology indicate...

Three in five people who contest a decision to reject their Personal Independence Payment win on appeal, figures have revealed.

Huge numbers of disabled people are being wrongly denied...

The immune system-suppressing multiple sclerosis (MS) drug Gilenya also has potentially beneficial effects on the nervous system, according to a recent study.

Gilenya is a relatively new...

Pages

Live Chat Software by Click4Assistance UK